1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • San-Juan R, Navarro D, García-Reyne A, Montejo M, Muñoz P, Carratala J, Len O, Fortun J, Muñoz-Cobo B, Gimenez E, Eworo A, Sabe N, Meije Y, Martín-Davila P, Andres A, Delgado J, Jimenez C, Amat P, Fernández-Ruiz M, López-Medrano F, Lumbreras C, Aguado JM, REIPI Network, Spain.

    Effect of delaying prophylaxis against CMV in D plus /R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease

    JOURNAL OF INFECTION . 71(5): 561-570. Nº de citas: 8

    [doi:10.1016/j.jinf.2015.06.013]

  • Casado JL, Esteban MA, Bañón S, Moreno A, Perez-Elías MJ, Mateos ML, Moreno S, Quereda C.

    Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response

    DIGESTIVE DISEASES AND SCIENCES . 60(11): 3473-3481. Nº de citas: 11

    [doi:10.1007/s10620-015-3773-y]

  • Cuervo G, Camoez M, Shaw E, Dominguez MÁ, Gasch O, Padilla B, Pintado V, Almirante B, Molina J, López-Medrano F, Ruiz de Gopegui E, Martinez JA, Bereciartua E, Rodriguez-Lopez F, Fernandez-Mazarrasa C, Goenaga MÁ, Benito N, Rodriguez-Baño J, Espejo E, Pujol M.

    Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients

    BMC INFECTIOUS DISEASES . 15(1): 484-484. Nº de citas: 3

    [doi:10.1186/s12879-015-1227-y]

  • Palladino C, Gómez ML, Soler-Palacín P, González-Tomé MI, De Ory SJ, Espiau M, Hoyos SP, León-Leal JA, Méndez M, Moreno-Pérez D, Guasch CF, Sierra AM, Guruceta IP, Guillén SM, Briz V.

    Off-label use of maraviroc in HIV-1-infected paediatric patients in clinical practice

    AIDS . 29(16): 2155-2159. Nº de citas: 3

    [doi:10.1097/QAD.0000000000000819]

  • Treviño A, Caballero E, de Mendoza C, Aguilera A, Pirón M, Soriano V.

    The Burden of Neglected HIV-2 and HTLV-1 Infections in Spain

    AIDS REVIEWS . 17(4): 212-219. Nº de citas: 10

  • Muñoz P, Kestler M, De Alarcon A, Miro JM, Bermejo J, Rodríguez-Abella H, Fariñas MC, Cobo Belaustegui M, Mestres C, Llinares P, Goenaga M, Navas E, Oteo JA, Tarabini P, Bouza E.

    Current Epidemiology and Outcome of Infective Endocarditis A Multicenter, Prospective, Cohort Study

    Medicine . 94(43): . Nº de citas: 76

    [doi:10.1097/MD.0000000000001816]

  • Navas E, Torner N, Broner S, Godoy P, Martínez A, Bartolomé R, Domínguez A.

    Economic costs of outbreaks of acute viral gastroenteritis due to norovirus in Catalonia (Spain), 2010-2011

    Bmc Public Health . 15(1): 999-999. Nº de citas: 13

    [doi:10.1186/s12889-015-2289-x]

  • García Comas L, Ordobás Gavín M, Sanz Moreno JC, Ramos Blázquez B, Gutiérrez Rodríguez A, Astray Mochales J, Moreno Guillén S.

    Prevalence of hepatitis C antibodies in the population aged 16-80 years in the Community of Madrid 2008-2009.

    JOURNAL OF MEDICAL VIROLOGY . 87(10): 1697-1701. Nº de citas: 22

    [doi:10.1002/jmv.24219]

  • San-Juan R, Navarro D, García-Reyne A, Montejo M, Muñoz P, Carratala J, Len O, Fortun J, Muñoz-Cobo B, Gimenez E, Eworo A, Sabe N, Meije Y, Martín-Davila P, Andres A, Delgado J, Jimenez C, Amat P, Fernández-Ruiz M, López-Medrano F, Lumbreras C, Aguado JM, REIPI Network.

    Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D plus /R- solid organ transplant recipients

    TRANSPLANT INFECTIOUS DISEASE . 17(5): 637-646. Nº de citas: 15

    [doi:10.1111/tid.12417]

  • de Egea V, Muñoz P, Valerio M, de Alarcón A, Lepe JA, Miró JM, Gálvez-Acebal J, García-Pavía P, Navas E, Goenaga MA, Fariñas MC, Vázquez EG, Marín M, Bouza E.

    Characteristics and Outcome of Streptococcus pneumoniae Endocarditis in the XXI Century A Systematic Review of 111 Cases (2000-2013)

    Medicine . 94(39): . Nº de citas: 33

    [doi:10.1097/MD.0000000000001562]

  • Blanco JR, Arroyo-Manzano D, Rojas-Liévano JF, Crespo M, Bravo I, Pasquau J, Garcia Del Toro M, Herrero C, Rivero A, Moreno S, Llibre JM.

    The Efficacy and Safety of Maraviroc Addition to a Stable Antiretroviral Regimen in Subjects with Suppressed Plasma HIV-RNA Is Not Influenced by Age

    AIDS RESEARCH AND HUMAN RETROVIRUSES . 31(9): 893-897. Nº de citas: 4

    [doi:10.1089/aid.2015.0016]

  • Falcon A, Cuevas MT, Rodriguez-Frandsen A, Reyes N, Pozo F, Moreno S, Ledesma J, Martínez-Alarcón J, Nieto A, Casas I.

    CCR5 deficiency predisposes to fatal outcome in influenza virus infection

    JOURNAL OF GENERAL VIROLOGY . 96(8): 2074-2078. Nº de citas: 42

    [doi:10.1099/vir.0.000165]

  • Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, van Sighem A, Reiss P, Miró JM, Ferrer E, Justice A, Gandhi N, Bucher HC, Furrer H, Moreno S, Monge S, Touloumi G, Pantazis N, Sterne J, Young JG, Meyer L, Seng R, Dabis F, Vandehende MA, Pérez-Hoyos S, Jarrín I, Jose S, Sabin C, Hernán MA, HIV-CAUSAL Collaboration.

    Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study

    LANCET HIV . 2(8): 335-343. Nº de citas: 37

    [doi:10.1016/S2352-3018(15)00108-3]

  • Llibre JM, Rivero A, Rojas JF, Garcia Del Toro M, Herrero C, Arroyo D, Pineda JA, Pasquau J, Masiá M, Crespo M, Blanco JR, Moreno S.

    Safety, efficacy and indications of prescription of maraviroc in clinical practice: Factors associated with clinical outcomes

    ANTIVIRAL RESEARCH . 120: 79-84. Nº de citas: 11

    [doi:10.1016/j.antiviral.2015.05.001]

  • Díaz L, Martínez-Bonet M, Sánchez J, Fernández-Pineda A, Jiménez JL, Muñoz E, Moreno S, Álvarez S, Muñoz-Fernández MÁ.

    Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-kappa B-dependent mechanism

    SCIENTIFIC REPORTS . 5: 12442-12442. Nº de citas: 44

    [doi:10.1038/srep12442]

  • Schultze A, Phillips AN, Paredes R, Battegay M, Rockstroh JK, Machala L, Tomazic J, Girard PM, Januskevica I, Gronborg-Laut K, Lundgren JD, Cozzi-Lepri A, EuroSIDA in EuroCOORD.

    HIV resistance testing and detected drug resistance in Europe

    AIDS . 29(11): 1379-1389. Nº de citas: 12

    [doi:10.1097/QAD.0000000000000708]

  • Martínez-Bonet M, Clemente MI, Serramía MJ, Moreno S, Muñoz E, Muñoz-Fernández MA.

    Immunological and pharmacological strategies to reactivate HIV-1 from latently infected cells::a possibility for HIV-1 paediatric patients?

    Journal of virus eradication . 1(3): 148-152. Nº de citas: 4

  • May MT, Justice AC, Birnie K, Ingle SM, Smit C, Smith C, Neau D, Guiguet M, Schwarze-Zander C, Moreno S, Guest JL, Monforte Ad, Tural C, Gill MJ, Bregenzer A, Kirk O, Saag M, Sterling TR, Crane HM, Sterne JA.

    Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 69(3): 348-354. Nº de citas: 34

    [doi:10.1097/QAI.0000000000000603]